---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-249225"
form_type: "8-K"
ticker: "CORT"
cik: "0001088856"
company_name: "CORCEPT THERAPEUTICS INC"
filed_at: "2022-09-22T23:59:59+00:00"
generated_at: "2026-06-23T07:54:36.261565+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Corcept extends exclusive specialty pharmacy agreement for Korlym with Optime to March 2024

## Summary
- Amendment extends Optime's exclusive dispensing services for Korlym to March 31, 2024.
- No financial terms disclosed; original agreement from August 2017.
- Optime remains sole specialty pharmacy for Korlym in the United States.

## SEC filing metadata
- accession: 0001193125-22-249225
- form_type: 8-K
- ticker: CORT
- cik: 0001088856
- company_name: CORCEPT THERAPEUTICS INC
- filed_at: 2022-09-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1088856/000119312522249225/0001193125-22-249225-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1088856/000119312522249225/d325698d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-249225
- JSON: https://secwatch.observer/filing/0001193125-22-249225.json
- Plain text: https://secwatch.observer/filing/0001193125-22-249225.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.